Physician

Roger Say Chan, M.D.

According to 2025 Medicare claims, Roger Chan, M.D. (NPI: 1164530606) practices cardiology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is OLYMPIA MULTI SPECIALTY CLINIC (NPI: 1356386783; TIN: 911367068) and primary practice location at 98502-8144. Chan is affiliated with the PSW ACO (ACO ID: A5323) and NW Momentum Health Partners ACO (ACO ID: A5612), participating under the MSSP model.

Chan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 822 traditional Medicare patients, billed 3,907 HCPCS/CPT codes, and received $411,650 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,455 prescription claims across 662 beneficiaries totaling $992,441 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 15 claims. Open Payments data shows 3 records totaling $207. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $159,522 and ending at $411,650. Concurrently, Part D prescription costs have risen steadily, from $43,046 to $992,441. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,767 to $362.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	734	1,890	$159,522
2016	1,167	4,202	$342,034
2017	1,144	4,163	$394,800
2018	1,156	4,363	$460,758
2019	1,231	5,120	$467,254
2020	1,071	3,512	$302,215
2021	1,115	3,988	$387,024
2022	862	3,176	$257,886
2023	909	4,123	$443,458
2024	822	3,907	$411,650

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	631	$43,046
2016	542	3,271	$277,190
2017	570	3,758	$339,546
2018	563	4,144	$446,713
2019	576	4,342	$524,457
2020	546	4,239	$548,760
2021	669	5,250	$675,839
2022	690	5,120	$704,821
2023	638	4,885	$782,471
2024	662	5,455	$992,441

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,844
2016	N/R	33	$2,331
2017	N/R	35	$1,601
2018	N/R	15	$594
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	263	265	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	167	247	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	647	1,012	$87
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	122	123	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	644	922	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	572	35,130	$673,439
Xarelto	Rivaroxaban	134	8,934	$164,418
Repatha Sureclick	Evolocumab	16	790	$15,128
Flecainide Acetate	Flecainide Acetate	145	12,179	$9,287
Multaq	Dronedarone Hcl	11	330	$8,269

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$207	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roger Say Chan, M.D.?

Tedicare shows public-source Medicare data for Roger Say Chan, M.D. (NPI 1164530606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roger Say Chan, M.D. have ACO affiliation data?

Roger Say Chan, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323) and NW Momentum Health Partners ACO (MSSP, ACO ID A5612).

What billing organization is linked to Roger Say Chan, M.D.?

Roger Say Chan, M.D. is linked to OLYMPIA MULTI SPECIALTY CLINIC (billing NPI 1356386783) in the available physician profile data.

Does Roger Say Chan, M.D. have Open Payments data?

Roger Say Chan, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.